GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » PEG Ratio

Godavari Drugs (BOM:530317) PEG Ratio : 10.89 (As of May. 17, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Godavari Drugs's PE Ratio without NRI is 261.46. Godavari Drugs's 5-Year EBITDA growth rate is 24.00%. Therefore, Godavari Drugs's PEG Ratio for today is 10.89.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Godavari Drugs's PEG Ratio or its related term are showing as below:

BOM:530317' s PEG Ratio Range Over the Past 10 Years
Min: 0.42   Med: 2.01   Max: 19.37
Current: 10.73


During the past 13 years, Godavari Drugs's highest PEG Ratio was 19.37. The lowest was 0.42. And the median was 2.01.


BOM:530317's PEG Ratio is ranked worse than
92.14% of 369 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs BOM:530317: 10.73

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Godavari Drugs PEG Ratio Historical Data

The historical data trend for Godavari Drugs's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs PEG Ratio Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 - 0.91 0.56 -

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 12.99

Competitive Comparison of Godavari Drugs's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's PEG Ratio falls into.



Godavari Drugs PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Godavari Drugs's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=261.45552560647/24.00
=10.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Godavari Drugs  (BOM:530317) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Godavari Drugs PEG Ratio Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines